Suppr超能文献

TRIM21 的缺失通过抑制化疗药物多柔比星诱导的铁死亡来减轻心脏毒性。

Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin.

机构信息

School of Medicine, Nankai University, Tianjin, China; Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA; Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.

Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA.

出版信息

EBioMedicine. 2021 Jul;69:103456. doi: 10.1016/j.ebiom.2021.103456. Epub 2021 Jul 4.

Abstract

BACKGROUND

Doxorubicin, an anthracycline chemotherapeutic agent, is widely used in the treatment of many cancers. However, doxorubicin posts a great risk of adverse cardiovascular events, which are thought to be caused by oxidative stress. We recently reported that the ubiquitin E3 ligase TRIM21 interacts and ubiquitylates p62 and negatively regulates the p62-Keap1-Nrf2 antioxidant pathway. Therefore, we sought to determine the role TRIM21 in cardiotoxicity induced by oxidative damage.

METHODS

Using TRIM21 knockout mice, we examined the effects of TRIM21 on cardiotoxicity induced by two oxidative damage models: the doxorubicin treatment model and the Left Anterior Descending (LAD) model. We also explored the underlying mechanism by RNA-sequencing of the heart tissues, and by treating the mouse embryonic fibroblasts (MEFs), immortalized rat cardiomyocyte line H9c2, and immortalized human cardiomyocyte line AC16 with doxorubicin.

FINDINGS

TRIM21 knockout mice are protected from heart failure and fatality in both the doxorubicin and LAD models. Hearts of doxorubicin-treated wild-type mice exhibit deformed mitochondria and elevated level of lipid peroxidation reminiscent of ferroptosis, which is alleviated in TRIM21 knockout hearts. Mechanistically, TRIM21-deficient heart tissues and cultured MEFs and H9c2 cells display enhanced p62 sequestration of Keap1 and are protected from doxorubicin-induced ferroptosis. Reconstitution of wild-type but not the E3 ligase-dead and the p62 binding-deficient TRIM21 mutants impedes the protection from doxorubicin-induced cell death.

INTERPRETATION

Our study demonstrates that TRIM21 ablation protects doxorubicin-induced cardiotoxicity and illustrates a new function of TRIM21 in ferroptosis, and suggests TRIM21 as a therapeutic target for reducing chemotherapy-related cardiotoxicity.

FUNDING

NIH (CA129536; DK108989): data collection, analysis. Shanghai Pujiang Program (19PJ1401900): data collection. National Natural Science Foundation (31971161): data collection. Department of Veteran Affairs (BX004083): data collection. Tianjin Science and Technology Plan Project (17ZXMFSY00020): data collection.

摘要

背景

多柔比星是一种蒽环类化疗药物,广泛用于治疗多种癌症。然而,多柔比星会导致严重的心血管不良事件,这些事件被认为是由氧化应激引起的。我们最近报道,泛素 E3 连接酶 TRIM21 相互作用并泛素化 p62,负调控 p62-Keap1-Nrf2 抗氧化途径。因此,我们试图确定 TRIM21 在氧化损伤引起的心脏毒性中的作用。

方法

使用 TRIM21 敲除小鼠,我们研究了 TRIM21 对两种氧化损伤模型(多柔比星治疗模型和左前降支模型)引起的心脏毒性的影响。我们还通过心脏组织的 RNA 测序,以及用多柔比星处理小鼠胚胎成纤维细胞(MEFs)、永生化大鼠心肌细胞系 H9c2 和永生化人心肌细胞系 AC16,探讨了潜在的机制。

结果

TRIM21 敲除小鼠在多柔比星和 LAD 模型中均能预防心力衰竭和死亡。多柔比星处理的野生型小鼠的心脏表现出变形的线粒体和脂质过氧化水平升高,类似于铁死亡,而 TRIM21 敲除的心脏则得到缓解。在机制上,TRIM21 缺陷的心脏组织和培养的 MEFs 和 H9c2 细胞显示出 Keap1 结合的 p62 增加,并能抵抗多柔比星诱导的铁死亡。野生型但不是 E3 连接酶失活和 p62 结合缺陷的 TRIM21 突变体的重建会阻碍多柔比星诱导的细胞死亡的保护作用。

结论

我们的研究表明,TRIM21 缺失可预防多柔比星引起的心脏毒性,并阐明了 TRIM21 在铁死亡中的新功能,并提示 TRIM21 可作为减少化疗相关心脏毒性的治疗靶点。

资助

美国国立卫生研究院(CA129536;DK108989):数据收集、分析。上海浦江计划(19PJ1401900):数据收集。国家自然科学基金(31971161):数据收集。退伍军人事务部(BX004083):数据收集。天津市科技计划项目(17ZXMFSY00020):数据收集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d486/8261003/08a027a58d9a/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验